Assessment of EGFR Mutation Status in Needle Biopsies and Cytology Specimens of Lung Adenocarcinoma by Immunohistochemistry Using Antibodies to the Two Major Forms of Mutant EGFR

被引：0
|
作者：
Ang, D. C. [1 ]
Brevet, M. [1 ]
Ladanyi, M. [1 ]
Zakowski, M. F. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
MODERN PATHOLOGY | 2010年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
382
引用
收藏
页码：87A / 87A
页数：1
相关论文
共 49 条
  • [21] Comparison of the effect of two EGFR-TKI in patients with EGFR-mutant lung adenocarcinoma using in silico clinical trials
    Darre, Hippolyte
    Martin, Bastien
    Hammami, Firas
    Nativel, Arnaud
    Lefaudeux, Diane
    Toueg, Raphael
    Duruisseaux, Michael
    Palgen, Jean-Louis
    Masson, Perrine
    L'Hostis, Adele
    Ceres, Nicoletta
    Monteiro, Claudio
    CANCER RESEARCH, 2023, 83 (07)
  • [22] Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning
    Wang, Shuo
    Shi, Jingyun
    Ye, Zhaoxiang
    Dong, Di
    Yu, Dongdong
    Zhou, Mu
    Liu, Ying
    Gevaert, Olivier
    Wang, Kun
    Zhu, Yongbei
    Zhou, Hongyu
    Liu, Zhenyu
    Tian, Jie
    EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (03)
  • [23] Using Vision Transformer for high robustness and generalization in predicting EGFR mutation status in lung adenocarcinoma
    Weng, Luoqi
    Xu, Yilun
    Chen, Yuhan
    Chen, Chengshui
    Qian, Qinqing
    Pan, Jie
    Su, Huang
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (06): : 1438 - 1445
  • [24] PREDICTION OF EGFR MUTATION STATUS IN LUNG ADENOCARCINOMA USING MULTI-SOURCE FEATURE REPRESENTATIONS
    Cheng, Jianhong
    Liu, Jin
    Jiang, Meilin
    Yue, Hailin
    Wu, Lin
    Wang, Jianxin
    2021 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH AND SIGNAL PROCESSING (ICASSP 2021), 2021, : 1350 - 1354
  • [25] Detection of EGFR gene mutation status from pleural effusions and other body fluid specimens in patients with lung adenocarcinoma
    Zhang, Ping
    Wu, Xiaonan
    Tang, Min
    Nie, Xin
    Li, Lin
    THORACIC CANCER, 2019, 10 (12) : 2218 - 2224
  • [26] Assessment of EGFR mutation status in carcinomas of the breast, colon, and uterine malignant mixed mullerian tumors by immunohistochemistry with mutation-specific antibodies
    Wen, Y. H.
    Brogi, E.
    Hasanovic, A.
    Ladanyi, M.
    Soslow, R.
    Shia, J.
    Moreira, A. L.
    HISTOPATHOLOGY, 2012, 61 : 149 - 149
  • [27] Lessons learned from routine, targeted assessment of liquid biopsies for EGFR T790M resistance mutation in patients with EGFR mutant lung cancers
    Mondaca, Sebastian
    Offin, Michael
    Borsu, Laetitia
    Myers, Mackenzie
    Josyula, Sowmya
    Makhnin, Alex
    Shen, Ronglai
    Riely, Gregory J.
    Rudin, Charles M.
    Ladanyi, Marc
    Yu, Helena A.
    Li, Bob T.
    Arcila, Maria E.
    ACTA ONCOLOGICA, 2019, 58 (11) : 1634 - 1639
  • [28] Detection of EGFR and KRAS gene mutations using suspension liquid-based cytology specimens in metastatic lung adenocarcinoma
    Zhao, Huan
    Qiu, Tian
    Guo, Huiqin
    Ying, Jianming
    Li, Junling
    Zhang, Zhihui
    ONCOTARGET, 2017, 8 (63) : 106685 - 106692
  • [29] EGFR Mutation Testing in Nonsmall Cell Lung Cancer Patients by Using Cytology Specimens When the Tissue Is No Longer the Issue
    Gil-Bazo, Ignacio
    Castanon, Eduardo
    Fusco, Juan P.
    CANCER CYTOPATHOLOGY, 2011, 119 (05) : 354 - 354
  • [30] Using Multi-phase CT Radiomics Features to Predict EGFR Mutation Status in Lung Adenocarcinoma Patients
    Zhang, Guojin
    Man, Qiong
    Shang, Lan
    Zhang, Jing
    Cao, Yuntai
    Li, Shenglin
    Qian, Rong
    Ren, Jialiang
    Pu, Hong
    Zhou, Junlin
    Zhang, Zhuoli
    Kong, Weifang
    ACADEMIC RADIOLOGY, 2024, 31 (06) : 2591 - 2600
12345